| Literature DB >> 28701292 |
Maritta Välimäki1,2,3, Kati Anneli Kannisto4,5, Tero Vahlberg2,6, Heli Hätönen4, Clive E Adams7.
Abstract
BACKGROUND: A text messaging service (short message service [SMS]) has the potential to target large groups of people with long-term illnesses such as serious mental disorders, who may have difficulty with treatment adherence. Robust research on the impact of mobile technology interventions for these patients remains scarce.Entities:
Keywords: medication adherence; psychotic disorders; randomized controlled trial; text messaging
Mesh:
Year: 2017 PMID: 28701292 PMCID: PMC5529737 DOI: 10.2196/jmir.7028
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Description of the short message service (SMS) text messaging interventiona.
| Categories | Description |
| Brief name | Tailored, patient-led SMS intervention. |
| Rationale and theory | The intervention is based on self-determination theory [ |
| Materials | Materials (and their users) were a computer with access to the Internet at the hospital (research nurses); mobile phone with a SIMb card to receive text messages (patients); a paper-format text message library, including a list of 85 text messages with the contact information of the research nurse and researchers (research nurses, patients). |
| Procedures | The patients selected their favorite text messages from a text message library. The research nurse input each person’s preferences of text messages into an electronic semiautomated system. |
| Providers | The semiautomated system was managed by nurses in psychiatric hospitals. |
| How? | Messages continued for 12 months or until participants no longer wanted to receive the messages. The messages did not include any personal health-related content (eg, identification codes or names, diagnoses, medication, or name of health services). Participants were advised to inform researchers or research nurses if their mobile number changed, if they felt at all uncomfortable because of the received text messages, or in case of any technical problems. |
| Where? | Patients received SMS messages after being discharged from psychiatric hospital. |
| When and how much? | The timing, frequency, and conditions under which SMS messages were to be stopped were decided by the participants. The total number of messages received, free of charge to patients, was limited to a maximum of 12 per month or 4 per week (the minimum was 2 per month related to medication). |
| Tailoring and modifications | Patients were able to stop or change the topic, frequency, or timing of any messages by sending an email, telephoning, text messaging, or mailing researchers or staff members. |
aModified from the template for intervention description and replication (TIDieR) checklist and guide, Hoffmann et al [19].
bSIM: subscriber identity module.
Figure 1Flow diagram of study participants. SMS: short message service.
Patient characteristics.
| Characteristic | SMSa (n=569) | Usual care (n=570) | |
| At trial entry | 38.5 (13); n=569 | 38.0 (12); n=569 | |
| At first contact with services | 27.4 (12); n=562 | 26.9 (11); n=560 | |
| Female sex, n (%) | 301/569 (52.9) | 278/570 (48.8) | |
| Single | 277/565 (49.0) | 309/569 (54.3) | |
| Married | 154/565 (27.3) | 151/569 (26.5) | |
| Divorced | 120/565 (21.2) | 99/569 (17.4) | |
| Widowed | 14/565 (2.5) | 10/569 (1.8) | |
| None | 177/561 (31.6) | 172/564 (30.5) | |
| Vocational training courses | 89/561 (15.9) | 79/564 (14.0) | |
| Primary vocational skill certificate | 161/561 (28.7) | 162/564 (28.7) | |
| Secondary vocational skill certificate | 80/561 (14.3) | 90/564 (16.0) | |
| University degree | 54/561 (9.6) | 61/564 (10.8) | |
| Employed | 108/560 (19.3) | 99/561 (17.6) | |
| Retired | 269/560 (48.0) | 277/561 (49.4) | |
| Self-employed | 15/560 (2.7) | 12/561 (2.1) | |
| Student | 60/560 (10.7) | 68/561 (12.1) | |
| Job seeker | 108/560 (19.3) | 105/561 (18.7) | |
| 1 | 9/455 (2.0) | 12/387 (3.1) | |
| ≥2 treatment periods or more | 446/455 (98.0) | 375/387 (97.0) | |
| Organic, including symptomatic, mental disorders (F00-F09) | 1/535 (0.2) | 2/520 (0.4) | |
| Mental and behavioral disorders due to psychoactive substance use (F10-F19) | 31/535 (5.8) | 29/520 (5.6) | |
| Schizophrenia, schizotypal and delusional disorders (F20-F29) | 212/535 (39.6) | 209/520 (40.2) | |
| Mood [affective] disorders (F30-F39) | 161/535 (30.1) | 163/520 (31.3) | |
| Neurotic, stress-related and somatoform disorders (F40-F49) | 48/535 (9.0) | 40/520 (7.7) | |
| Behavioral syndromes associated with physiological disturbances and physical factors (F50-F59) | 1/535 (0.2) | 4/520 (0.8) | |
| Disorders of adult personality and behavior (F60-F69) | 71/535 (13.3) | 63/520 (12.1) | |
| Mental retardation (F70-F79) | 4/535 (0.7) | 6/520 (1.2) | |
| Disorders of psychological development (F80-F89) | 3/535 (0.6) | 2/520 (0.4) | |
| Behavioral and emotional disorders with onset usually occurring in childhood and adolescence (F90-F98) | 1/535 (0.2) | 2/250 (0.4) | |
aSMS: short message service text message intervention group.
bICD-10: International Classification of Diseases, 10th Revision.
Primary and secondary outcome analysis.
| Outcomes | SMSa (n=563) | Usual care (n=556) | Coefficient (95% CI) | ||||
| Readmission to psychiatric hospital | 242/563 (43.0) | 216/556 (38.8) | RRb 1.11 (0.92 to 1.33) | .28 | |||
| Time to next hospitalization (days), median (IQRc) | 110.0 (44.0-14.0); n=242 | 104.5 (39.5-197.0); n=216 | MdDd 7.0 (–8.0 to 24.0) | .37 | |||
| Time in psychiatric hospital during the year (days), median (IQR) | 30.0 (12.0-67.0); n=242 | 24.0 (10.0-67.0); n=216 | MdD 2.0 (–2.0 to 7.0) | .35 | |||
| Healthy time (days), median (IQR) | 330.5 (285.0-350.0); n=242 | 338.0 (293.5=352); n=216 | MdD –4.0 (–10.0 to 1.0) | .08 | |||
| M1e referral | 78/442 (17.6) | 77/396 (19.4) | ORf 0.89 (0.57 to 1.38) | .59 | |||
| Mental examination | 0/442 (0) | 1/396 (0.3) | |||||
| Determination of treatment | 0/442 (0) | 0/396 (0) | |||||
| Other | 364/442 (82.4) | 318/396 (80.3) | OR 1.14 (0.74 to 1.77) | .54 | |||
| Involuntary treatment (number of periods of care), n (%) | 91/439 (20.7) | 95/390 (24.4) | RR 0.85 (0.61 to 1.18) | .33 | |||
| Use of private care | N/Ag | N/A | |||||
| Length of general hospital treatment (days), median (IQR) | 0.0 (0.0-0.0); n=563 | 0.0 (0.0-0.0); n=556 | MdD 0.0 (0.0 to 0.0) | .13 | |||
| Length of involuntary treatment (days), median (IQR) | 18.0 (5.0-61.0); n=76 | 23.0 (5.0-79.0); n=67 | MdD –2.0 (–13.0 to 2.0) | .35 | |||
| Coercive incidence (number of periods of care) | 27/442 (6.1) | 25/396 (6.3) | RR 0.97 (0.52 to 1.78) | .92 | |||
| Seclusion | 20/443 (4.5) | 25/396 (6.3) | RR 1.12 (0.57 to 2.20) | .75 | |||
| Limb restraint | 12/443 (2.7) | 9/396 (2.3) | RR 1.19 (0.37 to 3.80) | .77 | |||
| Forced injection | 2/443 (0.5) | 1/396 (0.3) | RR 1.79 (0.16 to 19.46) | .63 | |||
| Physical restraint | 6/443 (1.4) | 4/396 (1.0) | RR 1.34 (0.38 to 4.70) | .65 | |||
| Antipsychotic | 125/241 (51.9) | 117/216 (54.2) | RR 0.96 (0.74 to 1.23) | .74 | |||
| Antipsychotic + antidepressant | 131/241 (54.4) | 109/216 (50.5) | RR 1.08 (0.84 to 1.39) | .57 | |||
| Anyh (yes) | 6/563 (1.1) | 3/556 (0.5) | RR 1.97 (0.49 to 7.90) | .34 | |||
| Death (yes) | 11/563 (2.0) | 16/556 (2.9) | RR 0.68 (0.31 to 1.46) | .32 | |||
| Satisfied with care (CSQ-8i [ | 22.4 (5.0); n=268 | 23.1 (5.0); n=262 | MDj –0.69 (–1.50 to 0.18) | .12 | |||
| Request to stop SMSk, n (%) | 24/563 (4.3) | N/Al | |||||
| Left the study earlym, n (%) | 295/563 (52.4) | 294/556 (52.9) | RR 0.99 (0.84 to 1.16) | .91 | |||
| CORp 0.68 (0.47 to 0.97) | .04 | ||||||
| 46-100 | 106/442 (24.0) | 71/394 (18.0) | |||||
| 31-45 | 223/442 (50.5) | 189/394 (48.0) | |||||
| 1-30 | 113/442 (25.6) | 134/394 (34.0) | |||||
| Quality of life (Q-LES-Qq [ | 0.59 (0.18); n=268 | 0.59 (0.17); n=262 | MD 0.00 (–0.03 to 0.03) | 0.80 | |||
| Direct treatment costsr (€) (all) | 10,103/28 (26-9410); n=563 | 9210/0 (0-6936); n=556 | MdD 26.8 (26 to 27) | <.001 | |||
| Direct treatment costs (€) (readmitted patients) | 23,469/13,080 (5331-29,314); n=242 | 23,707/10,200 (4284-31,774); n=216 | MdD 845 (794 to 3132) | 0.25 | |||
| Indirect cost (€) | N/A | N/A | |||||
aSMS: short message service text message intervention group.
bRR: relative risk (Poisson regression).
cIQR: interquartile range.
dMdD: median difference (Hodges-Lehmann estimate, Mann-Whitney U test).
eM1 referral: referral for observation.
fOR: odds ratio (logistic regression).
gN/A: not available.
hMonitored by study investigators.
iCSQ-8: Client Satisfaction Questionnaire-8.
jMD: mean difference (2-sample t test).
kContact with the research team.
lN/A: not applicable.
mDid not return survey questionnaire.
nData from health register.
oGAS: Global Assessment Scale.
pCOR: cumulative odds ratio (<1 indicates less disability in the SMS group).
qQ-LES-Q: Quality of Life Enjoyment and Satisfaction Questionnaire
rTreatment cost per patient (€1=US $ 1.13, September 2015).
Adverse events reported during the trial.
| Adverse events | SMSa (n=563) | Usual care (n=560) | |
| Any | 6 (1.0) | 3 (0.5) | |
| Mild | 1 (0.2) | 1 (0.2) | |
| Moderateb | 1 (0.2) | 0 | |
| Severeb | 4 (0.7) | 2 (0.4) | |
| Expected, severe | 0 | 0 | |
| Life-threatening or fatalb | 3 (0.5) | 2 (0.4) | |
| Requiring or prolonging hospitalization | 0 | 0 | |
| Major disabilityb,c | 1 (0.2) | 0 | |
| Expected, less severe | 0 | 0 | |
| Medical | 1 (0.2) | 0 | |
| Psychiatric (paranoid thoughts) | 2 (0.4) | 1 (0.2) | |
| Substance use | 0 | 0 | |
aSMS: short message service text message intervention group.
bNot consequence of study.
cPhysical injury, not linked to study.